美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dermata Therapeutics, Inc.

0.0200

0.0000

成交量：102.00

成交額：2.04

市值：- -

市盈率：0.00

高：0.0200

開：0.0200

低：0.0200

收：0.0200

52周最高：0.0440

52周最低：0.0102

股本：- -

流通股本：- -

量比：0.00

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-28.3716

淨資產收益率：-203.36%

總資產收益率：-96.45%

市淨率：0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Dermata Therapeutics, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.dermatarx.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Dermata Therapeutics, Inc.於2014年12月在特拉華州。他們是一家臨床階段的醫學皮膚病學公司，專註於識別、開發和商業化用於治療醫學和美學皮膚病和病症的創新藥物候選產品，該公司認為由於目前的療法不足或不存在，這代表了重要的市場機會。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DRMAW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRMAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMAW\",,,,,undefined,":{"symbol":"DRMAW","market":"US","secType":"STK","nameCN":"Dermata Therapeutics, Inc.","latestPrice":0.02,"timestamp":1771621200000,"preClose":0.02,"halted":0,"volume":102,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":-28.3716,"marketStatus":"已收盤","change":0,"latestTime":"02-20 16:00:00 EST","open":0.02,"high":0.02,"low":0.02,"amount":2.039997,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-28.3716,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":5,"adr":0,"listingDate":1628827200000,"exchange":"NASDAQ","adjPreClose":0.02,"volumeRatio":0.003582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMAW\",,,,,undefined,":{"symbol":"DRMAW","floatShares":0,"roa":"-96.45%","roe":"-203.36%","lyrEps":0,"volumeRatio":0.003582,"shares":0,"dividePrice":0,"high":0.02,"amplitude":0,"preClose":0.02,"low":0.02,"week52Low":0.0102,"pbRate":"0.00","week52High":0.044,"institutionHeld":0,"latestPrice":0.02,"eps":-28.3716,"divideRate":0,"volume":102,"delay":0,"ttmEps":-28.3716,"open":0.02,"prevYearClose":0.0241,"prevWeekClose":0.0192,"prevMonthClose":0.0195,"prevQuarterClose":0.0241,"fiveDayClose":0.0192,"twentyDayClose":0.0214,"sixtyDayClose":0.0182},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRMAW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRMAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DRMAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.dermatarx.com","stockEarnings":[{"period":"1week","weight":0.0417},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0989},{"period":"6month","weight":-0.0783},{"period":"1year","weight":-0.3311},{"period":"ytd","weight":-0.1701}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Dermata Therapeutics, Inc.於2014年12月在特拉華州。他們是一家臨床階段的醫學皮膚病學公司，專註於識別、開發和商業化用於治療醫學和美學皮膚病和病症的創新藥物候選產品，該公司認為由於目前的療法不足或不存在，這代表了重要的市場機會。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":1.166367},{"month":2,"riseRate":0.4,"avgChangeRate":-0.205779},{"month":3,"riseRate":0.25,"avgChangeRate":-0.152877},{"month":4,"riseRate":0,"avgChangeRate":-0.219099},{"month":5,"riseRate":0.25,"avgChangeRate":0.076727},{"month":6,"riseRate":0.75,"avgChangeRate":0.236149},{"month":7,"riseRate":0.25,"avgChangeRate":-0.087839},{"month":8,"riseRate":0.5,"avgChangeRate":-0.045385},{"month":9,"riseRate":0.2,"avgChangeRate":-0.026317},{"month":10,"riseRate":0.6,"avgChangeRate":-0.08071},{"month":11,"riseRate":0.4,"avgChangeRate":0.020406},{"month":12,"riseRate":0.4,"avgChangeRate":-0.069608}],"exchange":"NASDAQ","name":"Dermata Therapeutics, Inc.","nameEN":"Dermata Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DRMAW\",market:\"US\",,,undefined,":null}}